ESR1 and breast carcinoma: RA restricts estrogen receptor α action in the estrogen-sensitive human breast cancer cell line MCF7/BUS (47), inhibits estrogen-induced proliferation of MCF-7 cells (48), and promotes ERα degradation and reduces its transcriptional activity in breast cancer cells (49).